BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37488275)

  • 21. External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients.
    Peilleron N; Seigneurin A; Herault C; Verry C; Bolla M; Rambeaud JJ; Descotes JL; Long JA; Fiard G
    World J Urol; 2021 May; 39(5):1489-1497. PubMed ID: 32583038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.
    Bianchi L; Schiavina R; Borghesi M; Bianchi FM; Briganti A; Carini M; Terrone C; Mottrie A; Gacci M; Gontero P; Imbimbo C; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Novara G; Porreca A; Volpe A; Brunocilla E
    Int J Urol; 2018 Jun; 25(6):574-581. PubMed ID: 29633372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients.
    Hueting TA; Cornel EB; Somford DM; Jansen H; van Basten JA; Pleijhuis RG; Korthorst RA; van der Palen JAM; Koffijberg H
    Eur Urol Oncol; 2018 Oct; 1(5):411-417. PubMed ID: 31158080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and Validation of a Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer.
    Li S; Zhao Z; Yang H; Wang D; Sun W; Li S; Zhang Z; Fu W
    Cancer Control; 2021; 28():10732748211027160. PubMed ID: 34155937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram.
    Weaver JK; Kim EH; Vetter JM; Shetty A; Grubb RL; Strope SA; Andriole GL
    Urology; 2018 Mar; 113():119-128. PubMed ID: 29217354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of machine learning in preoperative identification of lymph node metastasis status in endometrial cancer: a systematic review and meta-analysis.
    Ren Z; Chen B; Hong C; Yuan J; Deng J; Chen Y; Ye J; Li Y
    Front Oncol; 2023; 13():1289050. PubMed ID: 38173835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis.
    Zhu M; Gao J; Han F; Yin L; Zhang L; Yang Y; Zhang J
    Insights Imaging; 2023 Aug; 14(1):140. PubMed ID: 37606802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study.
    Diamand R; Oderda M; Albisinni S; Fourcade A; Fournier G; Benamran D; Iselin C; Fiard G; Descotes JL; Assenmacher G; Svistakov I; Peltier A; Simone G; Di Cosmo G; Roche JB; Bonnal JL; Van Damme J; Rossi M; Mandron E; Gontero P; Roumeguère T
    Urol Oncol; 2020 Nov; 38(11):847.e9-847.e16. PubMed ID: 32466877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel nomogram incorporating platelet-to-lymphocyte ratio for the prediction of lymph node involvement in prostate carcinoma.
    Merhe A; Labban M; Hout M; Bustros G; Abou Heidar N; El-Asmar JM; Bulbul M; El Hajj A
    Urol Oncol; 2020 Dec; 38(12):930.e1-930.e6. PubMed ID: 32736935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Establishment of New Thresholds for PLND-Validated Clinical Nomograms to Predict Non-Regional Lymph Node Metastases: Using
    Jiao J; Quan Z; Zhang J; Wen W; Qin J; Yang L; Meng P; Jing Y; Ma S; Wu P; Han D; Davis AA; Ren J; Yang X; Kang F; Zhang Q; Wang J; Qin W
    Front Oncol; 2021; 11():658669. PubMed ID: 33937073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment.
    Liu X; Wang X; Zhang Y; Sun Z; Zhang X; Wang X
    Abdom Radiol (NY); 2022 Sep; 47(9):3327-3337. PubMed ID: 35763053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, risk factors, and a predictive model for lymph node metastasis of submucosal (T1) colon cancer: A population-based study.
    Hu DY; Cao B; Li SH; Li P; Zhang ST
    J Dig Dis; 2019 Jun; 20(6):288-293. PubMed ID: 31021492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?
    Jansen BHE; Nieuwenhuijzen JA; Oprea-Lager DE; Yska MJ; Lont AP; van Moorselaar RJA; Vis AN
    Urol Oncol; 2019 Mar; 37(3):181.e1-181.e6. PubMed ID: 30558983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer.
    Roumiguié M; Beauval JB; Filleron T; Benoit T; Rischmann P; de la Taille A; Salomon L; Soulié M; Malavaud B; Ploussard G
    BJU Int; 2014 Dec; 114(6b):E113-E119. PubMed ID: 24684584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Schiavina R; Scattoni V; Castellucci P; Picchio M; Corti B; Briganti A; Franceschelli A; Sanguedolce F; Bertaccini A; Farsad M; Giovacchini G; Fanti S; Grigioni WF; Fazio F; Montorsi F; Rigatti P; Martorana G
    Eur Urol; 2008 Aug; 54(2):392-401. PubMed ID: 18456393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases.
    Fang Z; Wang R; Yang C; Wang D; Chen W; Lin B; Gong D; Li S; Liang J; Liang X; Zeng C; Li J; Wang K; Lv W
    Dis Markers; 2021; 2021():7879508. PubMed ID: 34853623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.